INBS
Intelligent Bio·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 0
Stock Price Surged Significantly
High Gross Profit Margin
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About INBS
Intelligent Bio Solutions Inc.
A life sciences company that developing intelligent, non-invasive, real-time testing solutions
Healthcare Equipment and Supplies
12/05/2016
12/23/2020
NASDAQ Stock Exchange
16
06-30
Common stock
135 West, 41ST Street, 5th Floor, New York, NY 10036
--
Intelligent Bio Solutions Inc., founded on December 5, 2016, is a Delaware corporation headquartered in New York City. The company is a life sciences company that develops non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. With its world's first biosensor platform, Intelligent Bio Solutions is developing and rolling out much-needed diagnostic tests to help patients with chronic diseases. In addition, with the recent acquisition of Smart Fingerprint, the company is a world leader in portable drug abuse detection through fingerprint sweat analysis. The trial was non-invasive, hygienic, fast and cost-effective, and screened for recent use of opioids, cocaine, methamphetamine, benzodiazepines and marijuana. Sample collection takes just seconds and results take ten minutes. Laboratory validation services are also provided. The system is used in many industries, and clients include employers in safety-critical industries such as construction, transport and logistics companies, drug rehabilitation agencies and UK coroners.
Company Financials
EPS
INBS has released its 2026 Q1 earnings. EPS was reported at -0.35, versus the expected -0.27, missing expectations. The chart below visualizes how INBS has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
INBS has released its 2026 Q1 earnings report, with revenue of 1.11M, reflecting a YoY change of 27.46%, and net profit of -2.99M, showing a YoY change of -11.14%. The Sankey diagram below clearly presents INBS's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
